3:30pm
to
5:00pm |
|
How Big Pharma Lost Its Edge-- The Future of Innovation in Drug Discovery and Development
(Seminar/Conference)
InskeepDMPK, LLC is a consulting firm that provides analysis and/or assessment of pharmacokinetic and drug metabolism data from preclinical or clinical studies for both human and veterinary medicines.
Phil Inskeep received a B.S. degree from Virginia Polytechnic Institute and State University and a Ph.D. degree from the Pennsylvania State University, both in biochemistry. He was a post-doctoral fellow at Vanderbilt University before starting his career in human and veterinary ADME (Absorption, Distribution, Metabolism, and Excretion) science at Pfizer. He is the author of over 30 research papers and 2 invited reviews spanning pharmacokinetics, clinical pharmacology, preclinical ADME, and other areas in biochemistry.
He has extensive experience in drug discovery and development including research, document management, regulatory interactions and filings, and business development.
More information...
|
